BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 20704726)

  • 1. A randomised controlled trial to evaluate the efficacy of a 6 month dietary and physical activity intervention for prostate cancer patients receiving androgen deprivation therapy.
    Haseen F; Murray LJ; O'Neill RF; O'Sullivan JM; Cantwell MM
    Trials; 2010 Aug; 11():86. PubMed ID: 20704726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomised controlled trial to evaluate the efficacy of a 6-month dietary and physical activity intervention for patients receiving androgen deprivation therapy for prostate cancer.
    O'Neill RF; Haseen F; Murray LJ; O'Sullivan JM; Cantwell MM
    J Cancer Surviv; 2015 Sep; 9(3):431-40. PubMed ID: 25916660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of a multi-component exercise programme and nutritional supplementation on musculoskeletal health in men treated with androgen deprivation therapy for prostate cancer (IMPACT): study protocol of a randomised controlled trial.
    Owen PJ; Daly RM; Livingston PM; Mundell NL; Dalla Via J; Millar JL; Fraser SF
    Trials; 2017 Oct; 18(1):451. PubMed ID: 28974267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mediterranean-style dietary pattern improves cancer-related fatigue and quality of life in men with prostate cancer treated with androgen deprivation therapy: A pilot randomised control trial.
    Baguley BJ; Skinner TL; Jenkins DG; Wright ORL
    Clin Nutr; 2021 Jan; 40(1):245-254. PubMed ID: 32534948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can supervised exercise prevent treatment toxicity in patients with prostate cancer initiating androgen-deprivation therapy: a randomised controlled trial.
    Cormie P; Galvão DA; Spry N; Joseph D; Chee R; Taaffe DR; Chambers SK; Newton RU
    BJU Int; 2015 Feb; 115(2):256-66. PubMed ID: 24467669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nutrition therapy with high intensity interval training to improve prostate cancer-related fatigue in men on androgen deprivation therapy: a study protocol.
    Baguley BJ; Skinner TL; Leveritt MD; Wright OR
    BMC Cancer; 2017 Jan; 17(1):1. PubMed ID: 28049525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A pilot study of exercise in men with prostate cancer receiving androgen deprivation therapy.
    Lee CE; Leslie WD; Lau YK
    BMC Cancer; 2012 Mar; 12():103. PubMed ID: 22436542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Individualized Diet and Exercise Adherence Pilot Trial (IDEA-P) in prostate cancer patients undergoing androgen deprivation therapy: study protocol for a randomized controlled trial.
    Focht BC; Lucas AR; Grainger E; Simpson C; Thomas-Ahner JM; Clinton SK
    Trials; 2014 Sep; 15():354. PubMed ID: 25199619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time on androgen deprivation therapy and adaptations to exercise: secondary analysis from a 12-month randomized controlled trial in men with prostate cancer.
    Taaffe DR; Buffart LM; Newton RU; Spry N; Denham J; Joseph D; Lamb D; Chambers SK; Galvão DA
    BJU Int; 2018 Feb; 121(2):194-202. PubMed ID: 28872752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality of life in prostate cancer patients taking androgen deprivation therapy.
    Dacal K; Sereika SM; Greenspan SL
    J Am Geriatr Soc; 2006 Jan; 54(1):85-90. PubMed ID: 16420202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of resistance training on body composition and metabolic syndrome variables during androgen deprivation therapy for prostate cancer: a pilot randomized controlled trial.
    Dawson JK; Dorff TB; Todd Schroeder E; Lane CJ; Gross ME; Dieli-Conwright CM
    BMC Cancer; 2018 Apr; 18(1):368. PubMed ID: 29614993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between circulating FSH levels and body composition and bone health in patients with prostate cancer who undergo androgen deprivation therapy: The BLADE study.
    Bergamini M; Dalla Volta A; Palumbo C; Zamboni S; Triggiani L; Zamparini M; Laganà M; Rinaudo L; Di Meo N; Caramella I; Bresciani R; Valcamonico F; Borghetti P; Guerini A; Farina D; Antonelli A; Simeone C; Mazziotti G; Berruti A
    Elife; 2024 Apr; 13():. PubMed ID: 38656229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physical function in men with prostate cancer on androgen deprivation therapy.
    Clay CA; Perera S; Wagner JM; Miller ME; Nelson JB; Greenspan SL
    Phys Ther; 2007 Oct; 87(10):1325-33. PubMed ID: 17684084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lifestyle changes for improving disease-specific quality of life in sedentary men on long-term androgen-deprivation therapy for advanced prostate cancer: a randomised controlled trial.
    Bourke L; Gilbert S; Hooper R; Steed LA; Joshi M; Catto JW; Saxton JM; Rosario DJ
    Eur Urol; 2014 May; 65(5):865-72. PubMed ID: 24119318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostate cancer - evidence of exercise and nutrition trial (PrEvENT): study protocol for a randomised controlled feasibility trial.
    Hackshaw-McGeagh L; Lane JA; Persad R; Gillatt D; Holly JM; Koupparis A; Rowe E; Johnston L; Cloete J; Shiridzinomwa C; Abrams P; Penfold CM; Bahl A; Oxley J; Perks CM; Martin R
    Trials; 2016 Mar; 17(1):123. PubMed ID: 26948468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of a Group-Mediated Exercise and Dietary Intervention in the Treatment of Prostate Cancer Patients Undergoing Androgen Deprivation Therapy: Results From the IDEA-P Trial.
    Focht BC; Lucas AR; Grainger E; Simpson C; Fairman CM; Thomas-Ahner JM; Buell J; Monk JP; Mortazavi A; Clinton SK
    Ann Behav Med; 2018 Apr; 52(5):412-428. PubMed ID: 29684136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nutrition care guidelines for men with prostate cancer undergoing androgen deprivation therapy: do we have enough evidence?
    Barnes KA; Ball LE; Galvão DA; Newton RU; Chambers SK
    Prostate Cancer Prostatic Dis; 2019 May; 22(2):221-234. PubMed ID: 30279584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized controlled trial on the effectiveness of strength training on clinical and muscle cellular outcomes in patients with prostate cancer during androgen deprivation therapy: rationale and design.
    Thorsen L; Nilsen TS; Raastad T; Courneya KS; Skovlund E; Fosså SD
    BMC Cancer; 2012 Mar; 12():123. PubMed ID: 22458865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term effects of androgen deprivation therapy in prostate cancer patients.
    Basaria S; Lieb J; Tang AM; DeWeese T; Carducci M; Eisenberger M; Dobs AS
    Clin Endocrinol (Oxf); 2002 Jun; 56(6):779-86. PubMed ID: 12072048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Muscle function, physical performance and body composition changes in men with prostate cancer undergoing androgen deprivation therapy.
    Storer TW; Miciek R; Travison TG
    Asian J Androl; 2012 Mar; 14(2):204-21. PubMed ID: 22367184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.